Innovations in MIGS: The Impact of Reimbursement Changes
How have changes in MIGS reimbursement affected clinical practice? On Innovation Journal Club, I. Paul Singh, MD, and Sahar Bedrood, MD, PhD, review a recent study that suggested physicians changed their approach to glaucoma management in the wake of changes to Medicare reimbursement. The two discuss how other proposed changes may alter the treatment landscape.
Survey Says: Treatment for a High-Risk Patient
On this episode of “Survey Says,” a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian M. Shafer, MD, to review a real case from Dr. Singh’s practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while preserving options for future treatment. Later, the panelists find out how their colleagues would manage the case based on the results of a social media poll of GT’s audience.
Supraciliary MIGS With Miniject
On MIGS Unplugged, Kaweh Mansouri, MD, MPH, sits down with hosts Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, to review supraciliary MIGS with the Miniject (iStar Medical). Dr. Mansouri provides placement pearls for the device to minimize complications and risk, and the surgeons discuss safety and efficacy data for the procedure. Dr. Mansouri also explains the patient selection criteria for the procedure—for treating open-angle glaucoma in either standalone or combined surgery.
Meeting Updates
YoungMD Connect Live
March 28–30; Austin, Texas
ASCRS Annual Meeting
April 25–28; Los Angeles
ARVO Annual Meeting
May 4–8; Salt Lake City
11th World Glaucoma Congress
June 25–28; Honolulu
43rd Congress of the ESCRS
September 12–16; Copenhagen
AAO Annual Meeting
October 17–20; Orlando, Florida
Interventional Glaucoma Consortium 2025
November 7–9; Salt Lake City
IGC Fellows Program
November 7–9; Salt Lake City
